Clik here to view.
SPAC engineering reaches new heights as scrapped deal sends pharma firm's...
Summary List PlacementAfter a novel SPAC buyback deal imploded, shares of clinical-stage biopharma company Immunovant plunged as much as 35.7% on Tuesday, according to a Bloomberg report.Drugmaker...
View ArticleClik here to view.
Billionaire investor Seth Klarman has nearly $900 million in SPACs — but...
Summary List PlacementBillionaire investor Seth Klarman's Baupost Group has nearly $900 million invested in special purpose acquisition companies, according to data compiled by CNBC.But during the...
View ArticleClik here to view.
Billionaire investor Bill Ackman's SPAC is reportedly being sued for not...
Summary List PlacementBillionaire hedge fund manager Bill Ackman's SPAC is being sued for not operating as a blank-check firm, the New York Times first reported Tuesday, a case that could affect the...
View ArticleClik here to view.
Bill Ackman will return his SPAC's $4 billion if his next-generation SPARC is...
Summary List PlacementBill Ackman will return his SPAC's $4 billion of cash to investors if regulators approve his next-generation acquisition vehicle, he revealed in a shareholder letter Friday. The...
View ArticleClik here to view.
Wall Street just heard a record scratch — and it could be a sign that the...
Summary List PlacementWall Street just heard a record scratch — loud, noxious and impossible to ignore. Since 2019 investors have been clamoring for Special Purpose Acquisition Companies (SPACs), but a...
View Article